New aminocyclitols with quaternary stereocentres via acylnitroso cycloaddition with an ipso,ortho arene dihydrodiol q a b s t r a c t Microbial ipso,ortho-dihydroxylation of benzoic acid by the B9 mutant strain of Ralstonia eutropha permits rapid construction of aminocyclitols containing a quaternary stereocentre. Installation of the amine functionality is achieved by use of an acylnitroso dienophile for a hetero-DielseAlder reaction. Both aminotetrols and aminohexols are accessible as single enantiomers by this route. Both NOESY spectroscopic and X-ray crystallographic analyses were required to distinguish cycloadduct isomers. Notably, subsequent to the biooxidation step, all new stereocentres are installed under substrate control. Thus, all stereochemical information is ultimately of enzymatic origin.
Introduction
The dearomatisationedihydroxylation of an arene by a microorganism was first reported by Gibson in 1968. 1 In the ensuing period, the arene cis-diol products of such biotransformations have been shown to be exceedingly versatile starting materials for synthesis. 2 For example, many natural products, 3 drug molecules, 4 polymers 5 and dyes 6 have all been synthesised by routes, which take advantage of the diverse functionality in these building blocks. Such syntheses are often of single enantiomers, as the metabolism of substituted arenes gives rise to enantiopure diols in most instances. The microorganisms employed for the production of arene cis-diols are usually those expressing benzene dioxygenase (BDO), toluene dioxygenase (TDO), naphthalene dioxygenase (NDO) and biphenyl dioxygenase (BPDO) enzymes. The regio-and stereochemical outcome of these biotransformations may be predicted by Boyd's model; 7 the sense of enantioinduction is conserved across organisms and substrates (Scheme 1a, ortho,meta-dihydroxylation).
However, organisms expressing benzoate dioxygenase (BZDO) 8 oxidise benzoic acids with both different regioselectivity and also the opposite absolute sense of enantioinduction (Scheme 1b, ipso,ortho-dihydroxylation). Certain substituted benzoic acids also undergo dearomatisationedihydroxylation. 9 The synthetic exploitation of ipso,ortho arene cis-diols such as 4 has been infrequent compared to ortho,meta arene cis-diols of type 2. Nevertheless, we 3a,j,9a,10 and others 3m,4,n,o,11 have reported uses of 4 in various synthetic contexts. Aminocyclitols (or 'azacarbasugars') are a privileged class of structures for drug development as they can serve as effective mimics of natural carbohydrates. The amino functionality can impart modified biological activity with respect to the parent carbohydrate and the lack of an endocyclic oxygen leads to enhanced hydrolytic stability. 12 Various aminocyclitols are currently in clinical use; 13 most notably, voglibose 5 14 and acarbose 6 15 are a-glucosidase inhibitors used to treat type II diabetes, as is the structurally related iminosugar miglitol 7 16 (Fig. 1 ). Voglibose is an N-alkylated derivative of a natural product, valiolamine 8, which itself possesses a-glucosidase inhibitory activity. 17 Aminocyclitols are also being used or evaluated as therapies for other diseases of carbohydrate metabolism, such as Noctylvalienamine 9, 18 amino derivatives 10e11 of myo-inositol, 19 bicyclic analogues 12e13, 20 triazolylamino derivatives 14 21 of scyllo-inositol and homologated calystegine 15 22 for Gaucher disease and 4-epi-N-octylvalienamine 16 13b,18,23 for G M1 -gangliosidosis. Aminocyclitols are core structural motifs of aminoglycoside antibiotics 12e,24 such as validamycin A 17 and antifungal activity of aminocyclitols such as salbostatin 18 has also been reported. 24e,25 In view of the many current and potential therapeutic applications of aminocyclitols, they have attracted a great degree of attention from the synthetic community. For example, syntheses of natural and non-natural aminocyclitols have been reported starting from carbohydrates by the Ferrier reaction, 26 from tricarbonyl(h 5cyclohexadienyl)iron complexes, 27 from inositols 28 and quercitols (deoxy-inositols), 29 from quinic acid 30 and by ring-closing metathesis. 30e, 31 The impetus to discover new glycosidase inhibitors has led chemists to target not only naturally occurring aminocyclitols but also novel structural variants such as medium rings 31h, 32 (e.g., 19e21) , polycyclics 30e,32d,33 (e.g., 22e25) and fluorinated derivatives 33a,34 (e.g., 26e27, Fig. 2 ).
Arene cis-diols are ideal starting materials for the synthesis of aminocyclitols 35 dthe first two hydroxyl groups are introduced in the biotransformation and additional hydroxyls may be introduced by a variety of further oxidative transformations. The ortho,meta arene cis-diols of type 2 have been used extensively for this purpose. The first report 36a dates from 1991, wherein Hudlick y reported introducing the amino functionality by means of an acylnitroso cycloaddition (Scheme 2a). This approach has also been used on two subsequent occasions. 36b,c Other reported methods for introduction of the nitrogen(s) are (i) alkene epoxidation and ring-opening with azide, 36b,37 phthalimide, 37d ammonia 38 or other amines 36b,39 (Scheme 2b), (ii) alkene aziridination 37b,e,38b,40 (Scheme 2c), including aziridine opening with nitrogen nucleophiles to access vicinal diaminocyclitols, 38b,40b (iii) displacement of a triflate by azide 34c (Scheme 2d) and (iv) addition of trimethylsilylazide to an enone 41 (Scheme 2e).
In contrast to ortho,meta arene cis-diols of type 2, the ipso,ortho arene cis-diols had not been used for aminocyclitol synthesis until our report in 2011 on the preparation from 4 of 'inosaminoacids' (44), zwitterionic aminocyclitols bearing a C-carboxy substituent. 42 In the present paper we describe the synthesis from 4 of aminocyclitols in which the side chain is in a lower oxidation state (45); these aminocyclitols were anticipated to have markedly different solubilities (due to their non-zwitterionic nature) and glycosidase inhibitory activities to those we have previously reported ( Fig. 3 ).
Results and discussion
Primary alcohol 46 is accessible from ipso,ortho arene cis-diol 4 by previously reported transformations: 11a,b,e ketalisation, esterification and reduction (we have found LiBH 4 to be the most effective reductant 3a ). We intended to introduce nitrogen functionality by means of an acylnitroso DielseAlder reaction whereby the dienophile is generated in situ under oxidative conditions (cf. Scheme 2a). Thus, protection of the free hydroxyl group was needed; introduction of a silyl ether proceeded to give 47 without any competing rearomatisation (a side reaction that can occur upon exposure of arene cis-diols to extremes of pH 43 ). Fully protected diene 47 underwent cycloaddition to afford two isomeric products, 48 and 49 (Scheme 3). The selectivity of cycloadditions employing dienes derived from arene cis-diols has been studied previously; 44 precedent suggested that approach of the dienophile to the diene face opposite the acetonide would be favoured. 11e,36a,45 NOESY spectra for both adducts showed correlations between the olefinic protons and the acetonide endo methyl protons, confirming the approach of the dienophile to the upper face. Distinguishing the two structures in which the Cbz group is distal (48) or proximal (49) to the silyl ether was not possible by NMR methods and required crystallographic analysis of a derivative (see below).
The residual alkenes in 48 and 49 were dihydroxylated under Upjohn conditions; cycloadduct 48 afforded a single cis-diol 50 in good yield, but surprisingly the corresponding transformation of 49 to cis-diol 51 was lower yielding and hampered by the formation of tetracyclic carbonate side-product 52. The structure of 52 was assigned on the basis of its molecular mass, a characteristic n (C ] O) absorbance at 1808 cm À1 and a 13 C NMR resonance at d¼154.4 ppm.
We propose that 52 is formed from 51 by attack of a newly introduced hydroxyl group on the carbamate carbonyl and CeN bond cleavage, followed by attack of the other hydroxyl group and extrusion of benzyl alcohol (Scheme 4). Also in support of the structure of 52, treatment of cis-diol 50 with TBAF did not give the expected desilylated structure 54, but instead gave cyclic carbonate 55, the structure of which was secured by X-ray crystallographic analysis ( Fig. 4 ). Cyclic carbonate 55 has n (C ] O) ¼1800 cm À1 and a 13 C NMR resonance at d¼154.6 ppm, comparable with 52.
Hydrogenolysis of diols 50 and 51, as well as their less highly oxygenated precursors 48 and 49 proceeded smoothly over palladium on carbon, effecting multiple reductive transformations in one-pot (NeO bond scission, Cbz deprotection, alkene reduction; Scheme 5). The more functionalised products 58 and 59 were isolated in lower yield than 56 and 57, which we ascribe to their unavoidable partial retention on Celite and/or silica.
The final removal of acid-labile protecting groups could be executed in a succinct manner simply by exposing 56e59 to aqueous hydrochloric acid, followed by an organic extraction to remove the lipophilic silanol byproduct. Concentration of the aqueous phase gave pure novel aminocyclitols 60e63 (Scheme 6). Aminotetrols 61 and 62 and aminohexols 63 and 64 were evaluated for the inhibition of glycosidase activity 46 against a-glucosidase (type I from Saccharomyces cerevisiae), b-glucosidase (almond), b-galactosidases (from Aspergillus oryzae and Escherichia coli) and b-glucuronidases (from bovine liver, E. coli and Patella vulgata); no inhibitory activity at 100 mM was observed.
Conclusion
We have described herein the synthesis of novel, densely functionalised aminocyclitols from a simple aromatic precursor, using a biotransformation and a hetero-DielseAlder reaction. The brevity of this route (nine steps from benzoic acid to products bearing six contiguous stereocentres, including a quaternary stereocentre) underscores the utility of microbial arene oxidation for the rapid introduction of complexity.
Experimental section

General
For general experimental methods, please see the Supplementary data. [1, 3] dioxol-3a-yl)methoxy)dimethylsilane (47). To alcohol 46 (548 mg, 3.01 mmol, 1.00 equiv) dissolved in dichloromethane (30 mL), triethylamine (1.06 mL, 7.52 mmol, 2.50 equiv) was added and stirred at 0 C. tert-Butyldimethylsilyl trifluoromethanesulfonate (0.829 mL, 3.61 mmol, 1.20 equiv) was added dropwise at 0 C over 5 min. The resulting mixture was stirred at 0 C for 1 h. The reaction mixture was transferred to a separating funnel, saturated brine (10 mL) was added then extracted with ethyl acetate (3Â10 mL). The organic phase was dried over magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure and purified via column chromatography (15% ethyl acetateepetrol) to give 47 (636 mg, 72%) as a colourless oil: R f 0.56 (15% ethyl acetateepetrol); [a] D 25 À137.5 (c 9.4, CH 2 Cl 2 ); n max (neat)/cm À1 2987, 2954, 2930, 2898, 2857, 1472, 1463, 1414, 1378, 1368, 1251, 1214, 1172, 1151, 1130, 1093, 1076, 1038, 1006, 938, 915, 834, 775, 709, 664, 1, 124.5, 122.6, 105.7, 80.1, 71.2, 65.8, 27.1, 26.5, 25.7, 18 
Representative examples of reported strategies for introduction of nitrogen in the synthesis of aminocyclitols from ortho,meta arene cis-diols. (48) and (3aR,4S,7R,7aR)-benzyl 7a-(((tert-butyldimethylsilyl)oxy)methyl)-2,2-dimethyl-3a,4,7,7a-tetrahydro-4,7-(epoxyimino)benzo[d] [1, 3] dioxole-8-carboxylate (49). To a solution of diene 47 (446 mg, 1.50 mmol, 1.00 equiv) and tetrabutylammonium periodate (1.30 g, 3.01 mmol, 2.00 equiv) in dichloromethane (30 mL) at À78 C was added N-(benzyloxycarbonyl)hydroxylamine (503 mg, 3.01 mmol, 2.00 equiv) in dichloromethane (10 mL) dropwise via cannula over 5 min. The reaction mixture was stirred at À78 C under N 2 for 20 h, then diluted with ethyl acetate (10 mL) and washed with saturated aqueous sodium thiosulfate solution (5 mL) and then brine (5 mL). The organic layer was separated and dried over magnesium sulfate, then concentrated under reduced pressure and purified by column chromatography (5% ethyl acetateepetrol) to give 48 (217 mg, 31%) as a colourless oil and 49 (403 mg, 58%) as a colourless oil. Compound 48: R f 0.19 (15% ethyl acetateepetrol); [a] D 25 þ1.53 (c 0.66, CH 2 Cl 2 ); n max (neat)/cm À1 3515, 2929, 2857, 1747, 1713, 1497, 1455, 1379, 1312, 1284, 1248, 1211, 1184, 1151, 1097, 1061, 1024, 984, 929, 910, 776, 751, 731, 696 , 2857, 1748, 1709, 1498, 1462, 1380, 1370, 1327, 1295, 1248, 1214, 1170, 1150, 1096, 1080, 1065, 1026, 1005, 934, 904, 836, 776, 736, 696, 683 [1, 3] dioxole-8-carboxylate (50). To alkene 48 (195 mg, 0.422 mmol, 1.00 equiv) in acetoneewater (4/1, 20 mL) was added N-methylmorpholine N-oxide (49 mg, 0.422 mmol, 1.00 equiv) as a solid. Osmium tetroxide (2.5% in tert-butanol, 80 mL, 8.4 mmol, 2.0 mol %) was added via syringe and the reaction mixture was stirred at room temperature for 48 h. A colour change from colourless to pale yellow was observed. The reaction mixture was transferred to a separating funnel, diluted with ethyl acetate (15 mL) and washed with saturated aqueous sodium thiosulfate (5 mL) and brine (5 mL). The organic phase was separated and dried over magnesium sulfate, concentrated under reduced pressure and purified by column chromatography (50% ethyl acetateepetrol) to give 50 (172 mg, 81%), as a colourless oil. R f 0.38 (40% ethyl acetateepetrol); [a] D 25 À27 (c 8.2, CHCl 3 ); n max (neat)/cm À1 3419, 2959, 2929, 2886, 2857, 1708, 1553, 1498, 1460, 1408, 1384, 1258, 1212, 1071, 836, 779; 1 d 156.8, 135.4, 128.2, 128.1, 127.9, 111.1, 82.0, 78.0, 76.4, 72.3, 67.9, 64.9, 61.8, 61.2, 26.5, 26.4, 25.7, 18 [1, 3] dioxole-8-carboxylate (51) and (3aS,4S,4aR,7-aR,8R,8aR)-7a-(((tert-butyldimethylsilyl)oxy)methyl)-6,6dimethylhexahydro-4,8-(epoxyimino)benzo [1,2-d:4 ,5-d 0 ]bis( [1, 3] dioxole)-2-one (52). To alkene 49 (489 mg, 1.06 mmol, 1.00 equiv) in acetoneewater (4/1, 20 mL) was added N-methylmorpholine Noxide (124 mg, 1.06 mmol, 1.00 equiv) as a solid. Osmium tetroxide (2.5% in tert-butanol, 160 mL, 0.011 mmol, 2.0 mol %) was added via syringe and the reaction mixture was stirred at room temperature for 48 h. A colour change from colourless to pale yellow was observed and the reaction mixture was transferred to a separating funnel, diluted with ethyl acetate (10 mL) and washed with saturated aqueous sodium thiosulfate (5 mL) then brine (5 mL). The organic phase was separated and dried over magnesium sulfate, concentrated under reduced pressure and purified by column chromatography (50% ethyl acetateepetrol) to give 51 (230 mg, 44%) and 52 (70 mg, 17%) both as colourless oils. Also isolated was recovered 49 (97 mg, 19%). Compound 51: R f 0.36 (50% ethyl acetateepetrol); [a] D 25 þ17 (c 11.5, CHCl 3 ); n max (neat)/cm À1 3428, 2929, 2856, 1710, 1498, 1454, 1383, 1256, 1102, 1064, 835, 777; 1 135.5, 128.5, 128.3, 128.3, 111.7, 83.1, 76.2, 73.2, 68.3, 66.0, 62.5, 61.4, 58.9, 26.7, 26.6, 25.9, 18.4, À5.5, À5.6 Compound 52: R f 0.57 (50% ethyl acetateepetrol); [a] D 25 À6.5 (c 3.5, CHCl 3 ); n max (neat)/cm À1 3270, 2955, 2930, 2857, 1808, 1463, 1361, 1254, 1166, 1077, 836, 779; 1 4, 110.9, 81.8, 73.7, 71.7, 69.9, 68.3, 66.2, 53.4, 26.9, 26.6, 25.8, 18.3, À5.4, À5.5 5. (3aS,4R,4aR,7aR, 8S,8aR )-4a-(Hydroxymethyl)-6,6dimethylhexahydro-4,8-(epoxyimino)benzo [1,2-d:4 ,5-d 0 ]bis( [1, 3] dioxole)-2-one (55). To silyl ether 50 (165 mg, 0.333 mmol, 1.00 equiv) in THF (20 mL) at 0 C was added tetrabutylammonium fluoride (0.33 mL, 1.0 M in THF, 1.00 equiv) dropwise over 5 min. The reaction mixture was stirred at 0 C for 12 h, then transferred to a separating funnel and diluted with ethyl acetate (20 mL) and washed with water (2Â10 mL). The organic phase was then washed further with brine (5 mL (20 mL) was added palladium on carbon (6.0 mg, 10 mass %). The reaction mixture was stirred under an atmosphere of H 2 at room temperature for 24 h, then filtered through Celite. The filtrate was concentrated under reduced pressure and purified by column chromatography (50% ethyl acetateepetrol) to give 56 as a colourless oil (43 mg, 99%). R f 0.85 (50% ethyl acetateepetrol); [a] D 25 À15 (c 0.55, CHCl 3 ); n max (neat)/cm À1 2961, 2927, 2854, 1590, 1519, 1463, 1392, 1300, 1251, 1215, 1151, 1033 1, 83.6, 80.1, 73.2, 65.1, 47.4, 28.1, 26.7, 25.9, 25.4, 24.5, 18.3, À5. 4, 83.1, 79.8, 67.3, 65.8, 52.3, 27.5, 26.3, 26.0, 25.9, 23.7, 18.3, À5.3, À5. [1,3]dioxole-4,5,6-triol (58) . To diol 50 (28 mg, 0.056 mmol, 1.0 equiv) in ethyl acetate (20 mL) was added palladium on carbon (5.0 mg, 20 mass %). The reaction mixture was stirred under an atmosphere of H 2 at room temperature for 24 h, then filtered through Celite. The filtrate was concentrated under reduced pressure and purified by column chromatography (10% methanole89% chloroforme1% triethylamine) to give 58 as a colourless oil (11 mg, 50%). R f 0.25 (15% methanole84% ethyl acetatee1% triethylamine); [a] D 25 þ43 (c 0.6, H 2 O); n max (neat)/cm À1 3324, 3256, 2965, 2813, 2787, 1432, 1376, 1244, 1156, 1020, 978, 836, 774; 1 
